Aquaculture disease management and dynamic dosing expert Aqua Pharma are joining forces with microbial fingerprinting experts KYTOS to develop SEATRU™, a unique new service platform offering shrimp farmers worldwide effective microbial control through precise dosing recommendations. The initiative is set to start in July 2022 with a two-year research project based in Indonesia with local partner eFishery, the world’s largest aquaculture tech startup. “Our priority at Aqua Pharma is to provide disease prevention and control systems to the aquaculture industry with fish and shrimp welfare at the forefront. We are delighted to have teamed up with KYTOS to further develop SEATRU™, a tool that will use the power of KYTOS technology to read the aquaculture microbiome of farms, anticipating and reducing disease thanks to individually tailored and precise dosing of eco-friendly health management solutions,” said Markus Wu, head of Office Indonesia for Solvay and Aqua Pharma at Aqua Pharma Group. “Shrimp farmers are currently hampered by a lack of reliable data on water quality and animal health, resulting in frequent unpredictable disease outbreaks. “Together our work on the SEATRU™ concept is transforming aquaculture by researching and developing advanced technologies in microbial monitoring, animal gut health, disinfectant treatments and artificial intelligence to create stable water conditions and ensure increased performance. The research project is due to run from July 2022 until mid-2024, after which commercial scaling will follow.